NO20082443L - 3-monosubstituerte tropanderivater som nociceptinreseptorligandere - Google Patents
3-monosubstituerte tropanderivater som nociceptinreseptorligandere Download PDFInfo
- Publication number
- NO20082443L NO20082443L NO20082443A NO20082443A NO20082443L NO 20082443 L NO20082443 L NO 20082443L NO 20082443 A NO20082443 A NO 20082443A NO 20082443 A NO20082443 A NO 20082443A NO 20082443 L NO20082443 L NO 20082443L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- monosubstituted
- heterocycloalkyl
- heteroaryl
- cycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73170305P | 2005-10-31 | 2005-10-31 | |
PCT/US2006/041925 WO2007053435A1 (en) | 2005-10-31 | 2006-10-27 | 3 -monosubstituted tropane derivatives as nociceptin receptor ligands |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20082443L true NO20082443L (no) | 2008-07-30 |
Family
ID=37670874
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20082443A NO20082443L (no) | 2005-10-31 | 2008-05-30 | 3-monosubstituerte tropanderivater som nociceptinreseptorligandere |
Country Status (20)
Country | Link |
---|---|
US (2) | US7479494B2 (de) |
EP (1) | EP1951721B1 (de) |
JP (1) | JP2009513664A (de) |
KR (1) | KR20080064175A (de) |
CN (1) | CN101351465A (de) |
AR (1) | AR056588A1 (de) |
AT (1) | ATE490252T1 (de) |
AU (1) | AU2006309085A1 (de) |
BR (1) | BRPI0618137A2 (de) |
CA (1) | CA2627546A1 (de) |
DE (1) | DE602006018645D1 (de) |
EC (1) | ECSP088410A (de) |
IL (1) | IL191049A0 (de) |
NO (1) | NO20082443L (de) |
PE (1) | PE20071159A1 (de) |
RU (1) | RU2008121743A (de) |
SG (1) | SG166811A1 (de) |
TW (1) | TW200800189A (de) |
WO (1) | WO2007053435A1 (de) |
ZA (1) | ZA200803718B (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2018380T3 (da) | 2006-05-19 | 2012-01-23 | Abbott Lab | CNS-aktiverede kondenserede bi-heterocyklisk-substituerede azabicykliske alkanderivater |
EP2433936A1 (de) * | 2007-08-31 | 2012-03-28 | Purdue Pharma LP | Piperidinverbindungen vom substituierten Chinoxalintyp und Anwendungen davon |
CA2730593A1 (en) * | 2008-07-16 | 2010-01-21 | Schering Corporation | Bicyclic heterocycle derivatives and use thereof as gpr119 modulators |
KR101333660B1 (ko) | 2008-07-21 | 2013-11-27 | 시오노기세이야쿠가부시키가이샤 | 치환-퀴녹살린-형 가교-피페리딘 화합물 및 그의 용도 |
ES2439767T3 (es) * | 2008-08-01 | 2014-01-24 | Purdue Pharma Lp | Compuestos de tetrahidropiridinilo y dihidropirrolilo y uso de los mismos |
WO2012009263A1 (en) | 2010-07-12 | 2012-01-19 | Temple University-Of The Commonwealth System Of Higher Education | Cocaine analogs and methods of preparation and uses thereof |
WO2015182724A1 (ja) | 2014-05-28 | 2015-12-03 | トーアエイヨー株式会社 | 置換トロパン誘導体 |
US11131530B2 (en) | 2018-01-29 | 2021-09-28 | Lawrence Livermore National Security, Llc | Opto-thermal laser detonator |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1265057B1 (it) * | 1993-08-05 | 1996-10-28 | Dompe Spa | Tropil 7-azaindolil-3-carbossiamidi |
DE19624668A1 (de) | 1996-06-20 | 1998-02-19 | Klinge Co Chem Pharm Fab | Verwendung von Pyridylalkan-, Pyridylalken- bzw. Pyridylalkinsäureamiden |
US6451816B1 (en) * | 1997-06-20 | 2002-09-17 | Klinge Pharma Gmbh | Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression |
EP0944627B1 (de) | 1996-11-26 | 2004-02-18 | Syngenta Limited | 8-azabicyclo 3.2.1]octan-, 8-azabicyclo 3.2.1]oct-6-en-, 9-azabicyclo 3.3.1]nonan-, 9-aza-3-oxabicyclo 3.3.1]nonan- und 9-aza-3-thiabicyclo 3.3.1]nonan-derivate, ihre herstellung und ihre verwendung als insektizide |
US7485650B2 (en) | 1998-07-27 | 2009-02-03 | Schering Corporation | High affinity ligands for nociceptin receptor ORL-1 |
ID29137A (id) * | 1998-07-27 | 2001-08-02 | Schering Corp | Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1 |
US20040067950A1 (en) | 1998-07-27 | 2004-04-08 | Schering-Plough Corporation | High affinity ligands for nociceptin receptor ORL-1 |
US6262066B1 (en) | 1998-07-27 | 2001-07-17 | Schering Corporation | High affinity ligands for nociceptin receptor ORL-1 |
TWI317360B (en) | 2001-11-07 | 2009-11-21 | Schering Corp | Heteroaryl derivatives as superior ligands for nociceptin receptor orl-1 |
TW200300757A (en) | 2001-11-16 | 2003-06-16 | Schering Corp | Azetidinyl diamines useful as ligands of the nociceptin receptor orl-1 |
-
2006
- 2006-10-26 PE PE2006001305A patent/PE20071159A1/es not_active Application Discontinuation
- 2006-10-27 AT AT06826822T patent/ATE490252T1/de not_active IP Right Cessation
- 2006-10-27 JP JP2008537972A patent/JP2009513664A/ja not_active Withdrawn
- 2006-10-27 AR ARP060104705A patent/AR056588A1/es not_active Application Discontinuation
- 2006-10-27 WO PCT/US2006/041925 patent/WO2007053435A1/en active Application Filing
- 2006-10-27 RU RU2008121743/04A patent/RU2008121743A/ru not_active Application Discontinuation
- 2006-10-27 BR BRPI0618137-6A patent/BRPI0618137A2/pt not_active IP Right Cessation
- 2006-10-27 KR KR1020087012155A patent/KR20080064175A/ko not_active Application Discontinuation
- 2006-10-27 CA CA002627546A patent/CA2627546A1/en not_active Abandoned
- 2006-10-27 SG SG201008032-3A patent/SG166811A1/en unknown
- 2006-10-27 AU AU2006309085A patent/AU2006309085A1/en not_active Abandoned
- 2006-10-27 TW TW095139885A patent/TW200800189A/zh unknown
- 2006-10-27 DE DE602006018645T patent/DE602006018645D1/de active Active
- 2006-10-27 CN CNA2006800499526A patent/CN101351465A/zh active Pending
- 2006-10-27 EP EP06826822A patent/EP1951721B1/de active Active
- 2006-10-30 US US11/589,388 patent/US7479494B2/en active Active
-
2008
- 2008-04-27 IL IL191049A patent/IL191049A0/en unknown
- 2008-04-29 ZA ZA200803718A patent/ZA200803718B/xx unknown
- 2008-04-29 EC EC2008008410A patent/ECSP088410A/es unknown
- 2008-05-30 NO NO20082443A patent/NO20082443L/no not_active Application Discontinuation
- 2008-12-18 US US12/338,384 patent/US7910603B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US7910603B2 (en) | 2011-03-22 |
ZA200803718B (en) | 2009-03-25 |
US20090105248A1 (en) | 2009-04-23 |
DE602006018645D1 (de) | 2011-01-13 |
JP2009513664A (ja) | 2009-04-02 |
TW200800189A (en) | 2008-01-01 |
BRPI0618137A2 (pt) | 2011-08-16 |
EP1951721B1 (de) | 2010-12-01 |
AU2006309085A1 (en) | 2007-05-10 |
AR056588A1 (es) | 2007-10-10 |
PE20071159A1 (es) | 2007-11-30 |
US7479494B2 (en) | 2009-01-20 |
WO2007053435A1 (en) | 2007-05-10 |
ATE490252T1 (de) | 2010-12-15 |
CA2627546A1 (en) | 2007-05-10 |
EP1951721A1 (de) | 2008-08-06 |
RU2008121743A (ru) | 2009-12-10 |
ECSP088410A (es) | 2008-05-30 |
US20070249604A1 (en) | 2007-10-25 |
SG166811A1 (en) | 2010-12-29 |
CN101351465A (zh) | 2009-01-21 |
IL191049A0 (en) | 2008-12-29 |
KR20080064175A (ko) | 2008-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20082443L (no) | 3-monosubstituerte tropanderivater som nociceptinreseptorligandere | |
CA2598294A1 (en) | Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivative | |
GEP20063958B (en) | 1-alkyl-1-azoniabicyclo [2.2.2] octane carbamate derivatives and their use as muscarinic receptor antagonists | |
NO20045103L (no) | Benzofuserte heteroarylamid-derivater av thienopyridiner anvendelige som terapeutiske midler, farmasoytiske blandinger omfattende de samme og fremgangsmater for deres anvendelse | |
TW200612909A (en) | Compounds | |
NO20063382L (no) | Nye kinolinderivater | |
WO2010038085A3 (en) | P38 map kinase inhibitors | |
PL2281829T3 (pl) | Immunogenne kompozycje PCV2 stosowane w zapobieganiu infekcjom PCV2 | |
WO2007127635A3 (en) | Diketo-piperazine and piperidine derivatives as antiviral agents | |
JP2011515412A5 (de) | ||
WO2008120761A1 (ja) | ヘテロアリール誘導体 | |
WO2006086447A3 (en) | Pyridazine derivatives and their use as therapeutic agents | |
WO2006052555A8 (en) | Niacin receptor agonists, compositions containing such compounds and methods of treatment | |
WO2007027532A3 (en) | Niacin receptor agonists, compositions containing such compounds and methods of treatment | |
TNSN06278A1 (en) | [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(4-bromo-3-methyl-5-propoxy-thiophen-2-yl)-methanone hydrochloride as an inhibitor of mast cell tryptase | |
AU2007271186C1 (en) | Combination of HMG-CoA reductase inhibitors with phosphodiesterase 4 inhibitors for the treatment of inflammatory pulmonary diseases | |
WO2007046868A3 (en) | Thiazolidine derivatives and their uses as therapeutic agents | |
WO2007057221A3 (en) | Pharmaceutical compositions for the treatment of inflammatory and obstructive airways diseases | |
JP2003519228A5 (de) | ||
JP2007525533A5 (de) | ||
WO2006078724A3 (en) | Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases | |
PT2281829E (pt) | Composições imunogénicas de pcv2 para utilização num método de prevenção de infecção de pcv2 | |
WO2003039469A3 (en) | Heteroaryl derivatives as superior ligands for nociceptin receptor orl-1 | |
SG137859A1 (en) | Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same | |
WO2006032525A3 (en) | Combinational therapy for treating cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |